Navigating Complexity > Steering Decisions > Building Solutions

How pharmaceutical companies are driving positive social change

Sustainability and corporate social responsibility (CSR) strategies have shown huge success across industries. The benefits include attracting customers (a 2015 Nielsen survey showed 66% people will pay more for sustainable brands, up from 55% in 2014 and 50% in 2013); attracting and retaining employees; reducing business costs by improving process and supply chain efficiency; and distinguishing your company above competition.

Will a new label extension help Merck realize a rare antimicrobial success story, and what does this mean for the fight against AMR?

In rare, positive news in the field of antibiotics, Merck recently announced the approval of Zerbaxa to combat two types of pneumonia commonly found in hospitals.

Are digital diagnostics the way forward in the battered field of Alzheimer's?

Alzheimer's continues to be a major and steadily growing problem for healthcare systems, with an estimated 5 million patients affected by the disease in the US alone.

From Systematic Literature Reviews to Indirect Treatment Comparisons – Where Do We Start and How Do We Succeed?

This article in ISMPPs May newsletter got me thinking about the way we evaluate literature. If we agree that there is a need to redefine the importance and focus of systematic literature reviews, don’t we also need to reevaluate the literature at the top of the evidence pyramid? I agree that not all evidence is created equally, but surely we should be putting a greater emphasis on patients' experience/voice when focussing on payers and regulators as the target audience.